Quarterly ResultMay 4, 2026, 04:13 PM
Evolus Q1 Revenue $73.1M; Adjusted EBITDA $0.6M; Reaffirms 2026 Outlook
AI Summary
Evolus, Inc. reported Q1 2026 financial results, achieving $73.1 million in global net revenue, a 7% increase year-over-year, and a second consecutive quarter of positive Adjusted EBITDA at $0.6 million. The company reaffirmed its full-year 2026 net revenue guidance of $327 million to $337 million and expects to achieve a low- to mid-single digit Adjusted EBITDA margin. Additionally, Evolus terminated its $50.0 million "at-the-market" sales agreement, under which no shares had been sold.
Key Highlights
- Q1 2026 Global Net Revenue: $73.1 million, a 7% increase over Q1 2025.
- Q1 2026 Adjusted EBITDA: $0.6 million, marking the second consecutive quarter of positive Adjusted EBITDA.
- Q1 2026 GAAP Operating Loss: $6.8 million, a significant improvement from $15.2 million loss in Q1 2025.
- Reaffirms Full-Year 2026 Net Revenue Guidance: $327 million to $337 million (10% to 13% growth).
- Reaffirms Full-Year 2026 Non-GAAP Operating Expenses: $210 million to $216 million.
- Terminated $50.0 million "at-the-market" sales agreement; no shares were sold under the agreement.
- Cash and cash equivalents: $49.8 million as of March 31, 2026.
- Long-term 2028 Net Revenue Outlook: $450 million to $500 million, with 13% to 15% Adjusted EBITDA margins.